Penumbra is a healthcare company focused on therapies. Co. designs, develops, manufactures and markets products and has a portfolio that addresses various medical conditions. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Indigo System, which is designed for aspiration mechanical thrombectomy, utilizing the Penumbra System in ischemic stroke. Co.'s vascular products also include the Ruby Coil System, which consists of detachable coils that are designed for peripheral applications. The PEN YTD return is shown above.
The YTD Return on the PEN YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether PEN YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the PEN YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|